Kyowa Kirin Korea Co., Ltd. clinical trials
A country office of Kyowa Kirin Co., Ltd.
The registry lists 6 studies whose lead sponsor is Kyowa Kirin Korea Co., Ltd.. 2 are recruiting or about to start. Per ClinicalTrials.gov, last updated Aug 29, 2025.
Registry sponsor names on this page
- Kyowa Kirin Korea Co., Ltd.6 studies
Something wrong with this grouping? Tell us on the Kyowa Kirin Co., Ltd. page.
Studies
Recruiting first, then most recently updated. Showing 6 of 6. All Kyowa Kirin Co., Ltd. studies →
- Post Marketing Surveillance Study to Observe Safety and Effectiveness of CRYSVITA® in S. Korean PatientsRecruitingNCT06202027
Sponsor listed in the registry: Kyowa Kirin Korea Co., Ltd.
- Post Marketing Surveillance Study to Observe Safety and Effectiveness of NEPHOXIL ® in S. Korea PatientsRecruitingNCT06186934
Sponsor listed in the registry: Kyowa Kirin Korea Co., Ltd.
- An Observational Study to Evaluate the Safety and Efficacy of Pegfilgrastim (Neulasta®)CompletedNCT03433560
Sponsor listed in the registry: Kyowa Kirin Korea Co., Ltd.
- A Phase 2 Study to Evaluate the Efficacy and Safety of AMG531 in Aplastic AnemiaCompletedNCT02094417Phase 2
Sponsor listed in the registry: Kyowa Kirin Korea Co., Ltd.
- A Study of KHK4827 (Brodalumab) in Subjects With Moderate to Severe Psoriasis in KoreaCompletedNCT02982005Phase 3
Sponsor listed in the registry: Kyowa Kirin Korea Co., Ltd.
- Two-Part, Open-Label, Multi-Center, Phase 1/2 Study of BIW-8962 as Monotherapy in Subjects With Lung CancerTerminatedNCT01898156Phase 1/2
Sponsor listed in the registry: Kyowa Kirin Korea Co., Ltd.